Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 22, 2023 10:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fulcrum Therapeutics, Inc. (FULC) Investors of Class Action and to Actively Participate

NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fulcrum Therapeutics,...
May 22, 2023 09:30 ET | Source: Medi-Tech Insights

Global Breath Analyzers Market is anticipated to witness a lucrative CAGR of ~15-17% by 2027 : Medi-Tech Insights

BRUSSELS, BELGIUM, May 22, 2023 (GLOBE NEWSWIRE) -- Breath Analyzer is a medical device which is used to measure the amount of alcohol in a person’s exhaled breath sample. The device primarily...
May 22, 2023 09:00 ET | Source: PolyPid Ltd.

PolyPid Announces FDA Agreement on the Design of SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for Prevention of Abdominal Colorectal Surgical Site Infections

Recruitment to Resume Imminently Top-line Results Expected in Mid-2024 PETACH TIKVA, Israel, May 22, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a...
May 22, 2023 09:00 ET | Source: XBiotech Inc.

FDA Authorizes Phase II Study for Natrunix in Rheumatoid Arthritis Patients

AUSTIN, Texas, May 22, 2023 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today reports that the FDA’s Division of Rheumatology has authorized the Company to initiate a Phase II clinical study to...
May 22, 2023 09:00 ET | Source: Meticulous Market Research Pvt. Ltd.

DTC Laboratory Testing Market Worth $7.92 Billion by 2030 - Exclusive Report by Meticulous Research®

Redding, California, May 22, 2023 (GLOBE NEWSWIRE) -- According to a new market research report, ‘Direct-to-consumer (DTC) Laboratory Testing Market By Application (Genetic Testing {Ancestry,...
May 22, 2023 09:00 ET | Source: Scilex Holding Company

Scilex Holding Company Added to the Preliminary List of the Russell 3000® Index and the Small-Cap Russell 2000® Index as part of the 2023 Russell Indexes Annual Reconstitution in June 2023

PALO ALTO, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (OTC: SRNEQ), an innovative...
May 22, 2023 09:00 ET | Source: Kaplan Fox & Kilsheimer LLP

Kaplan Fox Investigates Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT)

NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors who purchased Intercept Pharmaceuticals, Inc....
May 22, 2023 09:00 ET | Source: Lumos Pharma, Inc.

Lumos Pharma to Participate in World Orphan Drug Congress USA

AUSTIN, Texas, May 22, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for idiopathic Pediatric Growth Hormone...
May 22, 2023 08:58 ET | Source: Research and Markets

Global Genomics, Proteomics, and Epigenomics Sample Preparation Market Research Report 2023 Featuring Agilent Technologies, Bio-Rad, Illumina, Merck Millipore, Roche and Thermo Fisher Scientific

Dublin, May 22, 2023 (GLOBE NEWSWIRE) -- The "Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global...
May 22, 2023 08:47 ET | Source: Market.Us

Intravenous Immunoglobulin Market size to grow by USD 24.4 Billion by 2032, North America to account for 49.5% of the market growth - Market.us

New York, May 22, 2023 (GLOBE NEWSWIRE) -- The latest report on the Intravenous Immunoglobulin Market estimates register an incremental growth of USD 24.4 Billion by 2032 from USD 12.6 Billion in...
May 22, 2023 08:46 ET | Source: Growth Plus Reports

Hypertension Drugs Market is estimated to cross worth US$ 40.16 Billion by 2031 | Growth Plus Reports

Newark, New Castle, USA, May 22, 2023 (GLOBE NEWSWIRE) -- The global Hypertension Drugs Market is forecast to expand at 3.1% CAGR over the estimated time-period, as per Growth Plus Reports analysis....
May 22, 2023 08:30 ET | Source: Coherus BioSciences, Inc.

Coherus Announces U.S. Launch of UDENYCA® Autoinjector

– UDENYCA® AI is the only pegfilgrastim prefilled autoinjector product presentation available in the U.S. that can be administered either in-office or at-home – – UDENYCA® AI fulfills high unmet need...
May 22, 2023 08:30 ET | Source: Daxor Corporation

Daxor Corporation Announces Pricing of $4.0 Million Underwritten Public Offering

Oak Ridge, TN, May 22, 2023 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the pricing of...
May 22, 2023 08:15 ET | Source: Bernstein Liebhard LLP

FULCRUM THERAPEUTICS, INC. (NASDAQ: FULC) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulcrum Therapeutics, Inc.

Did you lose money on investments in Fulcrum Therapeutics, Inc.? If so, please visit Fulcrum Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
May 22, 2023 08:15 ET | Source: Panbela Therapeutics, Inc.

Panbela Announces Clinical Trial with Moffitt Cancer Center for Phase I/II Program in STK11 Mutant Non-Small Cell Lung Cancer

MINNEAPOLIS, May 22, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet...
May 22, 2023 08:05 ET | Source: Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals to Participate in a Panel on Interaction with the FDA at the World Orphan Drug Congress

Company also to provide a corporate overview in a separate session HANOVER, MD, May 22, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a...
May 22, 2023 08:00 ET | Source: Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals and Genpharm Announce Collaboration to Provide IMCIVREE® (setmelanotide) to Patients in Gulf Cooperation Council Countries

BOSTON, May 22, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families...
May 22, 2023 08:00 ET | Source: Nano-X Imaging LTD.

Nanox Announces First Quarter of 2023 Financial Results and Provides Business Update

Reports progress towards global supply chain development Ended the first quarter of 2023 with cash, cash equivalents, restricted cash and marketable securities of $91.0 million Management to host...
May 22, 2023 08:00 ET | Source: Rain Oncology Inc.

Rain Oncology Announces Topline Results from Phase 3 MANTRA Trial of Milademetan for the Treatment of Dedifferentiated Liposarcoma

– The Phase 3 MANTRA trial did not meet the primary endpoint of progression free survival vs. standard of care – – The median PFS was 3.6 months for milademetan versus 2.2 months for trabectedin with...
May 22, 2023 07:30 ET | Source: Abeona Therapeutics Inc.

Abeona Therapeutics Announces Date Change for First Quarter 2023 Portfolio Update Conference Call to May 24, 2023

CLEVELAND, May 22, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has changed the date of its previously announced First Quarter 2023 Portfolio Update conference...
May 22, 2023 07:30 ET | Source: BridgeBio Pharma, Inc.

BridgeBio Pharma Presents Updated Encouraging Clinical and Biomarker Data from its BBP-812 Canavan Disease Gene Therapy Program at the 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

- Following treatment, the N-acetylaspartate (NAA) levels of CANaspire participants are consistent with levels seen in individuals with milder Canavan disease based on findings from the Company’s...
May 22, 2023 07:00 ET | Source: Centessa Pharmaceuticals plc

Centessa Pharmaceuticals Receives Fast Track Designation from the U.S. FDA for SerpinPC for Hemophilia B

BOSTON and LONDON, May 22, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are...
May 22, 2023 07:00 ET | Source: Krystal Biotech, Inc.

Krystal Biotech Announces $160 Million Private Placement Equity Financing

PITTSBURGH, May 22, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the Company) (NASDAQ: KRYS), a biotechnology company focused on developing and commercializing genetic medicines for patients with...
May 22, 2023 07:00 ET | Source: Immunovant Inc.

Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023

Investigational New Drug (IND) application and Clinical Trial Application (CTA) for IMVT-1402 cleared by the FDA and MEDSAFE, respectivelyPhase 1 clinical trial in healthy subjects initiated in New...
May 22, 2023 07:00 ET | Source: Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals’ Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and Multiple NASH Biomarkers

- Improvements in physiologic liver function and key NASH biomarkers including ALT, ProC3, PIIINP and ELF - - Results reinforce rencofilstat’s direct antifibrotic mode of action; increases confidence...
May 22, 2023 07:00 ET | Source: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces Clinical Proof-of-Concept Study of TNX-1900 (Intranasal Potentiated Oxytocin)

Intranasal Oxytocin Blocks the Release of CGRP in Animal Models Intranasal Oxytocin is the Core Technology of TNX-1900 for Migraine Oxytocin Treatment Affects a Pathway that is Distinct from the...
May 22, 2023 07:00 ET | Source: BioCryst Pharmaceuticals, Inc.

BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Public Health Institute of Chile

RESEARCH TRIANGLE PARK, N.C., May 22, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Public Health Institute (ISP) of Chile has granted marketing...
May 22, 2023 06:30 ET | Source: Reviva Pharmaceuticals

Reviva Pharmaceuticals Announces Presentation of Clinical Pharmacology Studies Data on Brilaroxazine at the ASPET 2023 Annual Meeting

Data reinforce brilaroxazine’s differentiated clinical pharmacology and safety profile Brilaroxazine may be co-administered with other drugs metabolized by CYP3A inhibitors Metabolism and excretion...
May 22, 2023 06:09 ET | Source: Levi & Korsinsky, LLP

FULC LAWSUIT ALERT: Levi & Korsinsky Notifies Fulcrum Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fulcrum Therapeutics, Inc. ("Fulcrum" or the "Company") (NASDAQ: FULC) of a class action securities...
May 22, 2023 05:30 ET | Source: Nexstim Oyj

Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Hildén

Företagsmeddelande, Helsingfors, 22.05.2023 kl. 12.30 (EEST) Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Hildén Nexstim Abp (NXTMH:HEX) (”Nexstim” eller ”bolaget”) meddelar...
May 22, 2023 05:30 ET | Source: Nexstim Oyj

Nexstim Plc: Managers’ Transactions, Hildén

Company Announcement, Helsinki, 22 May 2023 at 12:30 PM (EEST) Nexstim Plc: Managers’ Transactions, Hildén Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces managers’ transactions as...
May 22, 2023 05:25 ET | Source: Nexstim Oyj

Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Weckroth

Företagsmeddelande, Helsingfors, 22.05.2023 kl. 12.25 (EEST) Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Weckroth Nexstim Abp (NXTMH:HEX) (”Nexstim” eller ”bolaget”) meddelar...
May 22, 2023 05:25 ET | Source: Nexstim Oyj

Nexstim Plc: Managers’ Transactions, Weckroth

Company Announcement, Helsinki, 22 May 2023 at 12:25 PM (EEST) Nexstim Plc: Managers’ Transactions, Weckroth Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces managers’ transactions as...
May 22, 2023 05:20 ET | Source: Nexstim Oyj

Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Forss

Företagsmeddelande, Helsingfors, 22.05.2023 kl. 12.20 (EEST) Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Forss Nexstim Abp (NXTMH:HEX) (”Nexstim” eller ”bolaget”) meddelar av...
May 22, 2023 05:20 ET | Source: Nexstim Oyj

Nexstim Plc: Managers’ Transactions, Forss

Company Announcement, Helsinki, 22 May 2023 at 12:20 PM (EEST) Nexstim Plc: Managers’ Transactions, Forss Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces managers’ transactions as...
May 22, 2023 05:15 ET | Source: Nexstim Oyj

Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Niemistö

Företagsmeddelande, Helsingfors, 22.05.2023 kl. 12.15 (EEST) Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Niemistö Nexstim Abp (NXTMH:HEX) (”Nexstim” eller ”bolaget”) meddelar...
May 22, 2023 05:15 ET | Source: Nexstim Oyj

Nexstim Plc: Managers’ Transactions, Niemistö

Company Announcement, Helsinki, 22 May 2023 at 12:15 PM (EEST) Nexstim Plc: Managers’ Transactions, Niemistö Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces managers’ transactions as...
May 22, 2023 05:10 ET | Source: Nexstim Oyj

Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Karvinen

Företagsmeddelande, Helsingfors, 22.05.2023 kl. 12.10 (EEST) Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Karvinen Nexstim Abp (NXTMH:HEX) (”Nexstim” eller ”bolaget”)...
May 22, 2023 05:10 ET | Source: Nexstim Oyj

Nexstim Plc: Managers’ Transactions, Karvinen

Company Announcement, Helsinki, 22 May 2023 at 12:10 PM (EEST) Nexstim Plc: Managers’ Transactions, Karvinen Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces managers’ transactions as...
May 22, 2023 05:00 ET | Source: CONSEGIC BUSINESS INTELLIGENCE PRIVATE LIMITED

Cardiac Medical Device Market Size to Surpass $ 99,349.84 Mn by 2030, exhibiting a CAGR of 6.8%

New York, May 22, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Consegic Business Intelligence, the global Cardiac Medical Device Market is expected to witness significant growth at a...
May 22, 2023 04:53 ET | Source: Research and Markets

Drafting Effective Pharmaceutical Patents Training Course

Dublin, May 22, 2023 (GLOBE NEWSWIRE) -- The "Drafting Effective Pharmaceutical Patents Training Course" conference has been added to ResearchAndMarkets.com's offering. The highly complex area of...
May 22, 2023 04:28 ET | Source: Research and Markets

The FDA (Food and Drug Administration) Drug Approval Process Training Course: A Practical Insight into FDA Requirements

Dublin, May 22, 2023 (GLOBE NEWSWIRE) -- The "The FDA (Food and Drug Administration) Drug Approval Process Training Course" conference has been added to ResearchAndMarkets.com's offering. The US...
May 22, 2023 03:45 ET | Source: Nexstim Oyj

Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Juokslahti

Företagsmeddelande, Helsingfors, 22.05.2023 kl 10.45 (EEST) Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Juokslahti Nexstim Abp (NXTMH:HEX) (”Nexstim” eller ”bolaget”)...
May 22, 2023 03:45 ET | Source: Nexstim Oyj

Nexstim Plc: Managers’ Transactions, Juokslahti

Company Announcement, Helsinki, 22 May 2023 at 10:45 AM (EEST) Nexstim Plc: Managers’ Transactions, Juokslahti Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces managers’ transactions as...
May 22, 2023 03:40 ET | Source: Nexstim Oyj

Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Laine

Företagsmeddelande, Helsingfors, 22.05.2023 kl 10.40 (EEST) Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Laine Nexstim Abp (NXTMH:HEX) (”Nexstim” eller ”bolaget”) meddelar av...
May 22, 2023 03:40 ET | Source: Nexstim Oyj

Nexstim Plc: Managers’ Transactions, Laine

Company Announcement, Helsinki, 22 May 2023 at 10:40 AM (EEST) Nexstim Plc: Managers’ Transactions, Laine Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces managers’ transactions as...
May 22, 2023 03:35 ET | Source: Nexstim Oyj

Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Hannula

Företagsmeddelande, Helsingfors, 22.05.2023 kl 10.35 (EEST) Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Hannula Nexstim Abp (NXTMH:HEX) (”Nexstim” eller ”bolaget”) meddelar...
May 22, 2023 03:35 ET | Source: Nexstim Oyj

Nexstim Plc: Managers’ Transactions, Hannula

Company Announcement, Helsinki, 22 May 2023 at 10:35 AM (EEST) Nexstim Plc: Managers’ Transactions, Hannula Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces managers’ transactions as...
May 22, 2023 03:30 ET | Source: Nexstim Oyj

Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Järnefelt

Företagsmeddelande, Helsingfors, 22.05.2023 kl 10.30 (EEST) Nexstim Abp: Transaktioner utförda av personer i ledande ställning, Järnefelt Nexstim Abp (NXTMH:HEX) (”Nexstim” eller ”bolaget”) meddelar...
May 22, 2023 03:30 ET | Source: Nexstim Oyj

Nexstim Plc: Managers’ Transactions, Järnefelt

Company Announcement, Helsinki, 22 May 2023 at 10:30 AM (EEST) Nexstim Plc: Managers’ Transactions, Järnefelt Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces managers’ transactions as...